A

Alliance Pharma PLC
LSE:APH

Watchlist Manager
Alliance Pharma PLC
LSE:APH
Watchlist
Price: 64.7 GBX Market Closed
Market Cap: 356.5m GBX

Net Margin
Alliance Pharma PLC

-6%
Current
-9%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-6%
=
Net Income
-10.7m
/
Revenue
178.8m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
UK
Alliance Pharma PLC
LSE:APH
349.7m GBP
-6%
US
Eli Lilly and Co
NYSE:LLY
985.4B USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
506.1B USD
27%
CH
Roche Holding AG
SIX:ROG
252.5B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
210.2B GBP
16%
CH
Novartis AG
SIX:NOVN
207.2B CHF
26%
US
Merck & Co Inc
NYSE:MRK
246.7B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
33%
IE
Endo International PLC
LSE:0Y5F
209B USD
-126%
US
Pfizer Inc
NYSE:PFE
142.4B USD
16%
No Stocks Found

Alliance Pharma PLC
Glance View

Market Cap
349.7m GBX
Industry
Pharmaceuticals

Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).

APH Intrinsic Value
102.25 GBX
Undervaluation 37%
Intrinsic Value
Price
A
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-6%
=
Net Income
-10.7m
/
Revenue
178.8m
What is the Net Margin of Alliance Pharma PLC?

Based on Alliance Pharma PLC's most recent financial statements, the company has Net Margin of -6%.

Back to Top